Whitefort Capital Management, LP In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Whitefort Capital Management, LP reported 13 stock positions worth $201.5 million . Its top holding was Arbutus Biopharma (ABUS) at 24.6% of the portfolio, followed by Endeavor Group Hold Class A (EDR, 14.2% ) and Roivant Sciences (ROIV, 13.7% ). Compared with Q2 2024, it opened 1 new position, sold out of 4, added to 5 and reduced 2. The biggest buy was a new position in Endeavor Group Hold Class A (EDR) and the biggest sale an exit from Liberty Media Corp.-Liber-New (LSXMK).
Location NEW YORK, NY
CIK 0001884931
Portfolio Value $201.5M (Q3 2024) Holdings 13 stocks · $201.5M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q2 2024 ABUS Arbutus Biopharma Corp. 24.58% 12,867,967 $49.5M No change EDR Endeavor Group Hold Class A 14.17% 1,000,000 $28.6M New ROIV Roivant Sciences Ltd. 13.69% 2,391,000 $27.6M No change JOYY Joyy Inc.-ADR 10.17% 565,878 $20.5M Add +168.3% GNW Genworth Financial Inc. 10.15% 2,986,960 $20.5M Add +49.6% LQDA Liquidia Corp. 8.44% 1,702,025 $17.0M Add +119.8% CORZ Core Scientific Inc. 6.75% 1,147,500 $13.6M Add +337.1% GSL Global Ship Lease Inc. Class A 4.85% 366,771 $9.8M No change NN Nextnav Inc. 4.66% 1,252,831 $9.4M Reduce -16.5% MHLD Maiden Holdings Ltd. 1.80% 2,048,163 $3.6M No change VATE Innovate Corp. 0.59% 320,131 $1.2M Add +148.4% OPK Opko Health Inc. 0.10% 134,490 $200K Reduce -66.6% TRINITY BIOTECH INVT LTD 0.04% 81,902 $90K No change
Other holdings (5): bonds, preferreds, convertibles and warrants · $18.1M (not counted above) Total filed on the 13F, all lines: $219.6M.
Portfolio Sells Q2 2024 → Q3 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▲ LSXMK Liberty Media Corp.-Liber-New Sold out 0.00% −7.05 NN Nextnav Inc. Reduce -16.5% 4.66% −3.83 ESPR Esperion Therapeutics Inc. Sold out 0.00% −3.56 OMEX Odyssey Marine Exploration Sold out 0.00% −1.87 PBI Pitney Bowes Inc. Sold out 0.00% −1.32 OPK Opko Health Inc. Reduce -66.6% 0.10% −0.25
Portfolio Buys Q2 2024 → Q3 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▼ EDR Endeavor Group Hold Class A New 14.17% +14.17 JOYY Joyy Inc.-ADR Add +168.3% 10.17% +5.75 CORZ Core Scientific Inc. Add +337.1% 6.75% +5.05 LQDA Liquidia Corp. Add +119.8% 8.44% +1.96 GNW Genworth Financial Inc. Add +49.6% 10.15% +1.74 VATE Innovate Corp. Add +148.4% 0.59% +0.04
Notes & Other Activity Q2 2024 → Q3 2024 Security Class Change vs Q2 2024 Shares / Principal Value ▼ INNOVATE CORP (VATE 7.5 08/01/26 *) NOTE 7.500% 8/0 · principal Add +41.1% 12,218,000 $4.1M CORZZ Core Scientific Inc. - 29 *W EXP 01/23/202 Sold out 250,000 $2.2Mbefore exit LANWF Lanvin Group Holdings Ltd.-27 *W EXP 01/14/202 Sold out 100,000 $4Kbefore exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 18 $391.6M ABUS, ROIV, JOYY, BALY, GNW Q1 2026 17 $316.6M ABUS, ROIV, JOYY, SOC, GNW Q4 2025 15 $317.7M ABUS, ROIV, BALY, OABI, JOYY Q3 2025 14 $287.4M ABUS, ROIV, GNW, JOYY, OABI Q2 2025 Amended 14 $239.0M JOYY, ROIV, ABUS, GNW, OABI Q1 2025 11 $185.2M ABUS, ROIV, JOYY, GNW, LQDA Q4 2024 13 $191.5M ABUS, ROIV, LQDA, GNW, CDZI Q3 2024 13 $201.5M ABUS, EDR, ROIV, JOYY, GNW Q2 2024 16 $143.4M ABUS, ROIV, NN, GNW, GSL Q1 2024 13 $153.2M GSL, ABUS, ROIV, LSXMK, GNW